Literature DB >> 15255931

Oligomeric potential of the M2 muscarinic cholinergic receptor.

Paul S-H Park1, James W Wells.   

Abstract

G protein-coupled receptors are known to exist as oligomers. Although such aggregates often are referred to as dimers, there is little direct evidence regarding their oligomeric size. In the present investigation, c-Myc-, FLAG-, and influenza hemagglutinin (HA)-tagged forms of the M2 muscarinic receptor have been coexpressed in Sf9 cells to probe for aggregates larger than a dimer. Immunochromatography, immunoprecipitation, and immunoblotting were carried out with various combinations of antibodies directed against the different epitopes to demonstrate that all three tagged forms of the receptor can be immunopurified within a single complex. Extracts of the M2 muscarinic receptor from Sf9 cells therefore contain aggregates that are at least trimeric, and the levels detected point to the existence of larger complexes. The data also suggest that the oligomers coexist with a sizeable population of monomers.

Mesh:

Substances:

Year:  2004        PMID: 15255931     DOI: 10.1111/j.1471-4159.2004.02536.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

Review 1.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

2.  Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer.

Authors:  Luca F Pisterzi; David B Jansma; John Georgiou; Michael J Woodside; Judy Tai-Chieh Chou; Stéphane Angers; Valerica Raicu; James W Wells
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

Review 3.  Oligomerization of G protein-coupled receptors: past, present, and future.

Authors:  Paul S-H Park; Slawomir Filipek; James W Wells; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2004-12-21       Impact factor: 3.162

Review 4.  Oligomers of D2 dopamine receptors: evidence from ligand binding.

Authors:  Philip G Strange
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 5.  Entropy and oligomerization in GPCRs.

Authors:  Rajkumar P Thummer; Matthew P Campbell; Mark K Dean; Marie J Frusher; Paul D Scott; Christopher A Reynolds
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

Review 7.  Fluorescent and bioluminescent protein-fragment complementation assays in the study of G protein-coupled receptor oligomerization and signaling.

Authors:  Pierre-Alexandre Vidi; Val J Watts
Journal:  Mol Pharmacol       Date:  2009-01-13       Impact factor: 4.436

8.  The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.

Authors:  Saskia Nijmeijer; Rob Leurs; Martine J Smit; Henry F Vischer
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

Review 9.  Lighting up multiprotein complexes: lessons from GPCR oligomerization.

Authors:  Francisco Ciruela; Jean-Pierre Vilardaga; Víctor Fernández-Dueñas
Journal:  Trends Biotechnol       Date:  2010-06-09       Impact factor: 19.536

10.  Dopamine D2 receptors form higher order oligomers at physiological expression levels.

Authors:  Wen Guo; Eneko Urizar; Michaela Kralikova; Juan Carlos Mobarec; Lei Shi; Marta Filizola; Jonathan A Javitch
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.